BDBM708510 3-(2-methyl-5-((7-(4- (oxetan-3-yl)piperazin-1- yl)heptyl)amino)-4- oxoquinazolin-3(4H)- yl)piperidine- 2,6-dione::US20240425475, Compound GT-02623

SMILES Cc1nc2cccc(NCCCCCCCN3CCN(C4COC4)CC3)c2c(=O)n1C1CCC(=O)NC1=O

InChI Key InChIKey=OLRQLSJBZOGNEB-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 708510   

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM708510(3-(2-methyl-5-((7-(4- (oxetan-3-yl)piperazin-1- yl...)
Affinity DataIC50: 2.52E+3nMAssay Description:1. According to the instructions of the CEREBLON BINDING kits, the compounds to be tested of the present invention and lenalidomide were serially dil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent